Organ-on-Chip Models in Regulatory Submissions: A Perspective on Evidentiary Weight

Authors

  • Fien Wauters Centre for Preclinical Modelling, Haspengouw Institute of Translational Medicine, Tongeren, Belgium Author
  • Hendrik Hasselwander Centre for Regulatory Science, Altmuhl Centre for Experimental Therapeutics, Eichstatt, Germany Author
  • Vuk Zdravkovic Centre for Preclinical Modelling, Pomoravlje Institute of Molecular Therapeutics, Jagodina, Serbia Author

DOI:

https://doi.org/10.5281/zenodo.22649331

Keywords:

Organ-on-Chip Models in Regulatory Submissions;, Translational medicine; Evidence synthesis;, Clinical implementation; Health services research

Abstract

Organ-on-Chip Models in Regulatory Submissions is an area of active development in translational medicine, with evidence that
has accumulated unevenly across its component questions. We review the current evidence base for organ-on-chip models in
regulatory submissions, spanning analytical, clinical, implementation, governance, and economic dimensions, focusing on where
practice has converged and where it continues to vary, and set out the practical considerations relevant to a service considering
its adoption. We conclude that selective, context-specific use is best supported by the evidence currently available, rather than
uniform adoption or avoidance

References

Alvez D, Dumitrescu A, et al. "Organ-on-Chip Models in Regulatory Submissions: a systematic review". J Transl Med 8(2011): 80-86. DOI: 10.2196/89834

Brankovic K, Kowalczyk B, et al. "Organ-on-Chip Models in Regulatory Submissions: a methodological appraisal". Clin Pharmacol Ther 10(2014): 91-98. DOI: 10.1007/s10916-024-02104-9

Castellani R, Ristic C, et al. "Organ-on-Chip Models in Regulatory Submissions: a multicentre analysis". Nat Rev Drug Discov 12(2017): 102-110. DOI: 10.3389/fdgth.2026.1896184

Dumitrescu A, Andric D, et al. "Organ-on-Chip Models in Regulatory Submissions: a prospective cohort study". Trials 14(2020): 113-122. DOI: 10.3390/diagnostics15162117

Eriksdottir B, Brankovic E, et al. "Organ-on-Chip Models in Regulatory Submissions: a randomised evaluation". Drug Discov Today 16(2023): 124-134. DOI: 10.4103/jrpp.jrpp_20_65

Farkas I, Ionescu F, et al. "Organ-on-Chip Models in Regulatory Submissions: a consensus statement". Clin Cancer Res 18(2011): 135-146. DOI: 10.3389/fdgth.2026.1763884

Grabowski P, Petrescu G, et al. "Organ-on-Chip Models in Regulatory Submissions: a retrospective analysis". BMJ Open 20(2014): 146-158. DOI: 10.2196/48297

Hendriksen W, Wojcik H, et al. "Organ-on-Chip Models in Regulatory Submissions: a validation study". J Clin Epidemiol 22(2017): 157-170. DOI: 10.1007/s00330-025-12031-z

Ionescu F, Foscarini I, et al. "Organ-on-Chip Models in Regulatory Submissions: a scoping review". Contemp Clin Trials 24(2020): 168-182. DOI: 10.3389/fdgth.2026.1699005

Jankowiak G, Grabowski J, et al. "Organ-on-Chip Models in Regulatory Submissions: a health-economic analysis". Ther Innov Regul Sci 26(2023): 179-185. DOI: 10.3389/fdgth.2026.1834800

Kowalczyk N, Novotna K, et al. "Organ-on-Chip Models in Regulatory Submissions: a systematic review". Br J Clin Pharmacol 28(2011): 190-197. DOI: 10.2196/69678

Lindqvist U, Urbanek L, et al. "Organ-on-Chip Models in Regulatory Submissions: a methodological appraisal". PLoS Med 30(2014): 201-209. DOI: 10.7759/cureus.46454

Marchetti D, Doncheva M, et al. "Organ-on-Chip Models in Regulatory Submissions: a multicentre analysis". Lancet 32(2017): 212-221. DOI: 10.1016/j.ssci.2025.107028

Novotna E, Eriksdottir N, et al. "Organ-on-Chip Models in Regulatory Submissions: a prospective cohort study". N Engl J Med 34(2020): 223-233. DOI: 10.2196/48633

Ostrowski L, Lindqvist O, et al. "Organ-on-Chip Models in Regulatory Submissions: a randomised evaluation". JAMA 36(2023): 234-245. DOI: 10.1371/journal.pone.0305949

Petrescu S, Szabo P, et al. "Organ-on-Chip Models in Regulatory Submissions: a consensus statement". Nat Med 38(2011): 245-257. DOI: 10.1371/journal.pdig.0000514

Quintero B, Balogh Q, et al. "Organ-on-Chip Models in Regulatory Submissions: a retrospective analysis". Cell Rep Med 40(2014): 256-269. DOI: 10.17219/acem/208596

Ristic C, Castellani R, et al. "Organ-on-Chip Models in Regulatory Submissions: a validation study". Clin Transl Sci 42(2017): 267-281. DOI: 10.7759/cureus.104086

Szabo J, Jankowiak S, et al. "Organ-on-Chip Models in Regulatory Submissions: a scoping review". Pharmacogenomics J 44(2020): 278-284. DOI: 10.1038/s41746-023-00852-5

Tarasov Q, Quintero T, et al. "Organ-on-Chip Models in Regulatory Submissions: a health-economic analysis". Regul Toxicol Pharmacol 46(2023): 289-296. DOI: 10.1016/j.mayocpiqo.2022.09.004

Urbanek Z, Zielinski U, et al. "Organ-on-Chip Models in Regulatory Submissions: a systematic review". Drug Saf 8(2011): 300-308. DOI: 10.1177/08404704241291226

Vasquez A, Alvez V, et al. "Organ-on-Chip Models in Regulatory Submissions: a methodological appraisal". Ann Intern Med 10(2014): 311-320. DOI: 10.1093/medlaw/fwad013

Wojcik H, Hendriksen W, et al. "Organ-on-Chip Models in Regulatory Submissions: a multicentre analysis". BMC Med 12(2017): 322-332. DOI: 10.2196/89834

Zielinski O, Ostrowski Z, et al. "Organ-on-Chip Models in Regulatory Submissions: a prospective cohort study". Sci Transl Med 14(2020): 333-344. DOI: 10.1007/s10916-024-02104-9

Andric V, Vasquez A, et al. "Organ-on-Chip Models in Regulatory Submissions: a randomised evaluation". J Transl Med 16(2023): 344-356. DOI: 10.3389/fdgth.2026.1896184

Balogh E, Emmerich B, et al. "Organ-on-Chip Models in Regulatory Submissions: a consensus statement". Clin Pharmacol Ther 18(2011): 355-368. DOI: 10.3390/diagnostics15162117

Chiriac F, Farkas C, et al. "Organ-on-Chip Models in Regulatory Submissions: a retrospective analysis". Nat Rev Drug Discov 20(2014): 366-380. DOI: 10.4103/jrpp.jrpp_20_65

Doncheva M, Marchetti D, et al. "Organ-on-Chip Models in Regulatory Submissions: a validation study". Trials 22(2017): 377-383. DOI: 10.3389/fdgth.2026.1763884

Emmerich T, Tarasov E, et al. "Organ-on-Chip Models in Regulatory Submissions: a scoping review". Drug Discov Today 24(2020): 388-395. DOI: 10.2196/48297

Foscarini C, Chiriac F, et al. "Organ-on-Chip Models in Regulatory Submissions: a health-economic analysis". Clin Cancer Res 26(2023): 399-407. DOI: 10.1007/s00330-025-12031-z

Alvez D, Dumitrescu A, et al. "Organ-on-Chip Models in Regulatory Submissions: a systematic review". BMJ Open 28(2011): 410-419. DOI: 10.3389/fdgth.2026.1699005

Brankovic K, Kowalczyk B, et al. "Organ-on-Chip Models in Regulatory Submissions: a methodological appraisal". J Clin Epidemiol 30(2014): 421-431. DOI: 10.3389/fdgth.2026.1834800

Castellani R, Ristic C, et al. "Organ-on-Chip Models in Regulatory Submissions: a multicentre analysis". Contemp Clin Trials 32(2017): 432-443. DOI: 10.2196/69678

Dumitrescu A, Andric D, et al. "Organ-on-Chip Models in Regulatory Submissions: a prospective cohort study". Ther Innov Regul Sci 34(2020): 443-455. DOI: 10.7759/cureus.46454

Eriksdottir B, Brankovic E, et al. "Organ-on-Chip Models in Regulatory Submissions: a randomised evaluation". Br J Clin Pharmacol 36(2023): 454-467. DOI: 10.1016/j.ssci.2025.107028

Farkas I, Ionescu F, et al. "Organ-on-Chip Models in Regulatory Submissions: a consensus statement". PLoS Med 38(2011): 465-479. DOI: 10.2196/48633

Grabowski P, Petrescu G, et al. "Organ-on-Chip Models in Regulatory Submissions: a retrospective analysis". Lancet 40(2014): 476-482. DOI: 10.1371/journal.pone.0305949

Hendriksen W, Wojcik H, et al. "Organ-on-Chip Models in Regulatory Submissions: a validation study". N Engl J Med 42(2017): 487-494. DOI: 10.1371/journal.pdig.0000514

Ionescu F, Foscarini I, et al. "Organ-on-Chip Models in Regulatory Submissions: a scoping review". JAMA 44(2020): 498-506. DOI: 10.17219/acem/208596

Jankowiak G, Grabowski J, et al. "Organ-on-Chip Models in Regulatory Submissions: a health-economic analysis". Nat Med 46(2023): 509-518. DOI: 10.7759/cureus.104086

Kowalczyk N, Novotna K, et al. "Organ-on-Chip Models in Regulatory Submissions: a systematic review". Cell Rep Med 8(2011): 520-530. DOI: 10.1038/s41746-023-00852-5

Lindqvist U, Urbanek L, et al. "Organ-on-Chip Models in Regulatory Submissions: a methodological appraisal". Clin Transl Sci 10(2014): 531-542. DOI: 10.1016/j.mayocpiqo.2022.09.004

Marchetti D, Doncheva M, et al. "Organ-on-Chip Models in Regulatory Submissions: a multicentre analysis". Pharmacogenomics J 12(2017): 542-554. DOI: 10.1177/08404704241291226

Novotna E, Eriksdottir N, et al. "Organ-on-Chip Models in Regulatory Submissions: a prospective cohort study". Regul Toxicol Pharmacol 14(2020): 553-566. DOI: 10.1093/medlaw/fwad013

Ostrowski L, Lindqvist O, et al. "Organ-on-Chip Models in Regulatory Submissions: a randomised evaluation". Drug Saf 16(2023): 564-578. DOI: 10.2196/89834

Petrescu S, Szabo P, et al. "Organ-on-Chip Models in Regulatory Submissions: a consensus statement". Ann Intern Med 18(2011): 575-581. DOI: 10.1007/s10916-024-02104-9

Quintero B, Balogh Q, et al. "Organ-on-Chip Models in Regulatory Submissions: a retrospective analysis". BMC Med 20(2014): 586-593. DOI: 10.3389/fdgth.2026.1896184

Ristic C, Castellani R, et al. "Organ-on-Chip Models in Regulatory Submissions: a validation study". Sci Transl Med 22(2017): 597-605. DOI: 10.3390/diagnostics15162117

Szabo J, Jankowiak S, et al. "Organ-on-Chip Models in Regulatory Submissions: a scoping review". J Transl Med 24(2020): 608-617. DOI: 10.4103/jrpp.jrpp_20_65

Tarasov Q, Quintero T, et al. "Organ-on-Chip Models in Regulatory Submissions: a health-economic analysis". Clin Pharmacol Ther 26(2023): 619-629. DOI: 10.3389/fdgth.2026.1763884

Urbanek Z, Zielinski U, et al. "Organ-on-Chip Models in Regulatory Submissions: a systematic review". Nat Rev Drug Discov 28(2011): 630-641. DOI: 10.2196/48297

Vasquez A, Alvez V, et al. "Organ-on-Chip Models in Regulatory Submissions: a methodological appraisal". Trials 30(2014): 641-653. DOI: 10.1007/s00330-025-12031-z

Wojcik H, Hendriksen W, et al. "Organ-on-Chip Models in Regulatory Submissions: a multicentre analysis". Drug Discov Today 32(2017): 652-665. DOI: 10.3389/fdgth.2026.1699005

Zielinski O, Ostrowski Z, et al. "Organ-on-Chip Models in Regulatory Submissions: a prospective cohort study". Clin Cancer Res 34(2020): 663-677. DOI: 10.3389/fdgth.2026.1834800

Andric V, Vasquez A, et al. "Organ-on-Chip Models in Regulatory Submissions: a randomised evaluation". BMJ Open 36(2023): 674-680. DOI: 10.2196/69678

Downloads

Published

2025-03-11

How to Cite

Organ-on-Chip Models in Regulatory Submissions: A Perspective on Evidentiary Weight. (2025). Translational Medicine & Therapeutics Journal, 4(1), 19-27. https://doi.org/10.5281/zenodo.22649331

Similar Articles

51-60 of 64

You may also start an advanced similarity search for this article.